Radiology • February 21, 2025
“Nicole’s story is a common one in the world of women’s health,” said Julie Bulman, MD, “Being able to offer all the available treatments for symptomatic fibroids empowers women to choose the best option for them. Uterine artery embolization provides an outpatient procedure with a rapid recovery for women who are eligible and allows uterine preservation.”
Medicine • February 20, 2025
The Department of Medicine is delighted to announce the promotions of four new Professors of Medicine at Harvard Medical School: Eileen Reynolds, MD; Mara Schonberg, MD, MPH; Kari Nadeau, MD, PhD; and Roger Shapiro, MD, MPH. Please join us in congratulating these extraordinary members of our faculty on their well-deserved promotions!
Medicine • February 19, 2025
Richard Schwartzstein, MD, FACP, has been recognized with the Jane F. Desforges Distinguished Teacher Award from the American College of Physicians. Established in 1968, the award is bestowed upon a FACP or MACP who has demonstrated the ennobling qualities of a great teacher as judged by the accomplishments of former students.
Anesthesia • February 18, 2025
He spoke about his new role and his enthusiasm to get started on this exciting project: “The program provides an opportunity to work closely with the Journal Editorial Board, gaining insights into the editorial process while contributing to projects relevant to scholarly publishing. It is designed to support early-career researchers in developing their roles as educators, authors, and peer reviewers. I’m looking forward to learning from this experience and bringing back valuable insights to our department.” Click to learn more.
Pathology • February 13, 2025
Ramy Arnaout, MD, PhD, Associate Medical Director of Clinical Microbiology, and James Kirby, MD, Medical Director of Clinical Microbiology, two BIDMC Pathology physicians who are scientific co-founders of a company called AstraDx, Inc., are excited to share that Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award AstraDx $3M to demonstrate feasibility ahead of development for a low-cost instrument to detect neonatal sepsis. “We believe this will be a major step forward in diagnostics that presumably has implications beyond neonates.” Read more.
“The largest contributor to preventable death from medical error is diagnostic error, not procedural or pharmaceutical error,” said Michael Laposata, MD, PhD, at the Grand Rounds of The BIDMC Department of Pathology. Clinical laboratory leaders, anatomic pathologists, and radiologists have an opportunity to fill this knowledge gap and cross what he called the “divide in medicine” between diagnostic experts and treatment experts. Read more.
